Medical Condition News

RSS

Children who overreact to stressors may be at risk of becoming overweight or obese

Children who overreact to stressors may be at risk of becoming overweight or obese, according to researchers at Penn State and Johns Hopkins University.

16 Feb 2013

Study identifies regions of genes linked to Beh-et's disease

Researchers don't know the exact cause of Beh-et's disease, a chronic condition that leads to oral and genital sores and serious complications such as blindness, but new research brings better understanding to what makes some people more susceptible to being affected.

16 Feb 2013

MSU to launch levetiracetam clinical trial for treatment of African children with epilepsy

Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy each year.

16 Feb 2013

Hospitals may be unfairly punished for high readmission rates

When hospital patients have to be readmitted soon after discharge, hospitals look bad. A high readmission rate also can result in reduced Medicare reimbursements. But a study of spine surgery patients has found that the standard method used to calculate readmission rates is a misleading indicator of hospital quality.

16 Feb 2013

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant.

16 Feb 2013

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Genzyme, a Sanofi company, today announced positive new data from the Phase 3 ENGAGE and ENCORE studies of eliglustat tartrate, its investigational oral therapy for Gaucher disease type 1.

15 Feb 2013

Gedunin could help kill cancer cells

Scientists at the Georgia Regents University Cancer Center have identified an Indian plant, used for centuries to treat inflammation, fever and malaria, that could help kill cancer cells.

15 Feb 2013

Study discovers new predictor for suicidal thinking

When people lose hope that they will ever get another good night's sleep, they become at high risk for suicide, researchers report.

15 Feb 2013

New insights into how cells stick to each other and to other bodily structures

Research carried out by scientists at the Georgia Institute of Technology and The University of Manchester has revealed new insights into how cells stick to each other and to other bodily structures, an essential function in the formation of tissue structures and organs. It's thought that abnormalities in their ability to do so play an important role in a broad range of disorders, including cardiovascular disease and cancer.

15 Feb 2013

Negative obesity stories could discourage men in African-American community from taking action

Obesity rates have increased dramatically in the last few decades. According to the U.S. Census Bureau, African Americans make up more than 60 percent of the overweight and obese population, while only 13 percent of the total population.

15 Feb 2013

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

U.S. Marshals, acting on behalf of the U.S. Food and Drug Administration, today seized tainted dietary supplements from Globe All Wellness, LLC (Globe All), in Hollywood, Fla. The products may be unsafe because they contain an undisclosed active pharmaceutical ingredient.

15 Feb 2013

BioAlliance Pharma to extend Validive phase II trial in head and neck cancer

BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces the extension of its phase II clinical trial with Validive in the United States in radio/chemotherapy-induced oral mucositis prevention in patients with head and neck cancer.

15 Feb 2013

Protein-restricted diet supplemented with IGF-I may protect from Alzheimer's

Mice with many of the pathologies of Alzheimer's Disease showed fewer signs of the disease when given a protein-restricted diet supplemented with specific amino acids every other week for four months.

15 Feb 2013

Researchers identify new molecular pathway involved in alveoli growth

In a study of mice, researchers at Johns Hopkins have identified a new molecular pathway involved in the growth of tiny air sacs called alveoli that are crucial for breathing. The scientists say their experiments may lead to the first successful treatments to regrow the air sacs in people who suffer from diseases such as emphysema in which the air sacs have been destroyed by years of smoking.

15 Feb 2013

Patient-specific cancer cell lines designed to predict chemotherapy sensitivity

In laboratory studies, scientists at the Johns Hopkins Kimmel Cancer Center have developed a way to personalize chemotherapy drug selection for cancer patients by using cell lines created from their own tumors.

15 Feb 2013

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.

15 Feb 2013

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Tumors are not factories for the mass production of identical cancer cells, but are, in reality, patchworks of cells with different patterns of gene mutations. In a new study, researchers at Dana-Farber Cancer Institute and the Broad Institute show, more fully than ever before, how these mutations shift and evolve over time in chronic lymphocytic leukemia (CLL) - providing a strobe-like look at the genetic past, present, and future of CLL tumors.

15 Feb 2013

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).

15 Feb 2013

Physical activity may reduce risk of depression in patients undergoing bariatric surgery

Adults undergoing bariatric surgery who are more physically active are less likely to have depressive symptoms and to have recently received medication or counseling for depression or anxiety than their less active counterparts, according to new research led by the University of Pittsburgh Graduate School of Public Health.

15 Feb 2013

People with resilient personality profile more likely to have greater energy levels

People with a more resilient personality profile are more likely to have greater energy levels. That's one of the conclusions from a four-year research project led by Antonio Terracciano, associate professor of geriatrics at the Florida State University College of Medicine. His findings are outlined in "Personality, Metabolic Rate and Aerobic Capacity," published in PLOS ONE, a peer-reviewed, open access journal.

15 Feb 2013

Medical Condition News

Children who overreact to stressors may be at risk of becoming overweight or obese

Study identifies regions of genes linked to Beh-et's disease

MSU to launch levetiracetam clinical trial for treatment of African children with epilepsy

Hospitals may be unfairly punished for high readmission rates

FDA approves Novartis’ Zortress to prevent organ rejection after liver transplantation in adults

Positive new data from Genzyme’s eliglustat tartrate Phase 3 studies on Gaucher disease type 1

Gedunin could help kill cancer cells

Study discovers new predictor for suicidal thinking

New insights into how cells stick to each other and to other bodily structures

Negative obesity stories could discourage men in African-American community from taking action

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

BioAlliance Pharma to extend Validive phase II trial in head and neck cancer

Protein-restricted diet supplemented with IGF-I may protect from Alzheimer's

Researchers identify new molecular pathway involved in alveoli growth

Patient-specific cancer cell lines designed to predict chemotherapy sensitivity

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

Researchers show how gene mutations shift and evolve over time in chronic lymphocytic leukemia

Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis

Physical activity may reduce risk of depression in patients undergoing bariatric surgery

People with resilient personality profile more likely to have greater energy levels

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News